BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bassetti M, Baguneid M, Bouza E, Dryden M, Nathwani D, Wilcox M. European perspective and update on the management of complicated skin and soft tissue infections due to methicillin-resistant Staphylococcus aureus after more than 10 years of experience with linezolid. Clinical Microbiology and Infection 2014;20:3-18. [DOI: 10.1111/1469-0691.12463] [Cited by in Crossref: 59] [Cited by in F6Publishing: 57] [Article Influence: 8.4] [Reference Citation Analysis]
Number Citing Articles
1 Mazuski JE, Tessier JM, May AK, Sawyer RG, Nadler EP, Rosengart MR, Chang PK, O'Neill PJ, Mollen KP, Huston JM, Diaz JJ Jr, Prince JM. The Surgical Infection Society Revised Guidelines on the Management of Intra-Abdominal Infection. Surg Infect (Larchmt). 2017;18:1-76. [PMID: 28085573 DOI: 10.1089/sur.2016.261] [Cited by in Crossref: 201] [Cited by in F6Publishing: 147] [Article Influence: 50.3] [Reference Citation Analysis]
2 Lan SH, Lin WT, Chang SP, Lu LC, Chao CM, Lai CC, Wang JH. Tedizolid Versus Linezolid for the Treatment of Acute Bacterial Skin and Skin Structure Infection: A Systematic Review and Meta-Analysis. Antibiotics (Basel) 2019;8:E137. [PMID: 31487837 DOI: 10.3390/antibiotics8030137] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
3 Gu FF, Chen Y, Dong DP, Song Z, Guo XK, Ni YX, Han LZ. Molecular Epidemiology of Staphylococcus aureus among Patients with Skin and Soft Tissue Infections in Two Chinese Hospitals. Chin Med J (Engl) 2016;129:2319-24. [PMID: 27647191 DOI: 10.4103/0366-6999.190673] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
4 Simonetti O, Morroni G, Ghiselli R, Orlando F, Brenciani A, Xhuvelaj L, Provinciali M, Offidani A, Guerrieri M, Giacometti A, Cirioni O. In vitro and in vivo activity of fosfomycin alone and in combination with rifampin and tigecycline against Gram-positive cocci isolated from surgical wound infections. J Med Microbiol 2018;67:139-43. [PMID: 29154746 DOI: 10.1099/jmm.0.000649] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 2.8] [Reference Citation Analysis]
5 Wilcox M, Al-Obeid S, Gales A, Kozlov R, Martínez-Orozco JA, Rossi F, Sidorenko S, Blondeau J. Reporting elevated vancomycin minimum inhibitory concentration in methicillin-resistant Staphylococcus aureus: consensus by an International Working Group. Future Microbiol 2019;14:345-52. [PMID: 30724113 DOI: 10.2217/fmb-2018-0346] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
6 Russo A, Concia E, Cristini F, De Rosa FG, Esposito S, Menichetti F, Petrosillo N, Tumbarello M, Venditti M, Viale P, Viscoli C, Bassetti M. Current and future trends in antibiotic therapy of acute bacterial skin and skin-structure infections. Clin Microbiol Infect 2016;22 Suppl 2:S27-36. [PMID: 27125562 DOI: 10.1016/S1198-743X(16)30095-7] [Cited by in Crossref: 83] [Cited by in F6Publishing: 33] [Article Influence: 20.8] [Reference Citation Analysis]
7 Russo A. Spotlight on New Antibiotics for the Treatment of Pneumonia. Clin Med Insights Circ Respir Pulm Med 2020;14:1179548420982786. [PMID: 33424231 DOI: 10.1177/1179548420982786] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
8 Delpech P, Aleryan M, Jones B, Gemmell C, Lang S. An in vitro evaluation of the efficacy of tedizolid: implications for the treatment of skin and soft tissue infections. Diagnostic Microbiology and Infectious Disease 2018;91:93-7. [DOI: 10.1016/j.diagmicrobio.2018.01.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
9 Pulido-Cejudo A, Guzmán-Gutierrez M, Jalife-Montaño A, Ortiz-Covarrubias A, Martínez-Ordaz JL, Noyola-Villalobos HF, Hurtado-López LM. Management of acute bacterial skin and skin structure infections with a focus on patients at high risk of treatment failure. Ther Adv Infect Dis 2017;4:143-61. [PMID: 28959445 DOI: 10.1177/2049936117723228] [Cited by in Crossref: 18] [Cited by in F6Publishing: 28] [Article Influence: 4.5] [Reference Citation Analysis]
10 Cogo A, Gonzalez-Ruiz A, Pathan R, Hamed K. Real-World Treatment of Complicated Skin and Soft Tissue Infections with Daptomycin: Results from a Large European Registry (EU-CORE). Infect Dis Ther 2015;4:273-82. [PMID: 26168987 DOI: 10.1007/s40121-015-0074-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
11 Dryden M, Andrasevic AT, Bassetti M, Bouza E, Chastre J, Baguneid M, Esposito S, Giamarellou H, Gyssens I, Nathwani D, Unal S, Voss A, Wilcox M. Managing skin and soft-tissue infection and nosocomial pneumonia caused by MRSA: a 2014 follow-up survey. Int J Antimicrob Agents 2015;45 Suppl 1:S1-14. [PMID: 25867210 DOI: 10.1016/S0924-8579(15)30002-9] [Cited by in Crossref: 12] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
12 Hoover R, Hunt T, Benedict M, Paulson SK, Lawrence L, Cammarata S, Sun E. Safety, Tolerability, and Pharmacokinetic Properties of Intravenous Delafloxacin After Single and Multiple Doses in Healthy Volunteers. Clinical Therapeutics 2016;38:53-65. [DOI: 10.1016/j.clinthera.2015.11.019] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 6.0] [Reference Citation Analysis]
13 Lane S, Johnston K, Sulham KA, Syed I, Pollack CV Jr, Holland T, Nathwani D. Identification of Patient Characteristics Influencing Setting of Care Decisions for Patients With Acute Bacterial Skin and Skin Structure Infections: Results of a Discrete Choice Experiment. Clin Ther 2016;38:531-44; quiz 544.e1-9. [PMID: 26874786 DOI: 10.1016/j.clinthera.2016.01.007] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
14 Pérez-Laguna V, García-Luque I, Ballesta S, Rezusta A, Gilaberte Y. Photodynamic Therapy Combined with Antibiotics or Antifungals against Microorganisms That Cause Skin and Soft Tissue Infections: A Planktonic and Biofilm Approach to Overcome Resistances. Pharmaceuticals (Basel) 2021;14:603. [PMID: 34201530 DOI: 10.3390/ph14070603] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Ferrández O, Urbina O, Grau S. Critical role of tedizolid in the treatment of acute bacterial skin and skin structure infections. Drug Des Devel Ther 2017;11:65-82. [PMID: 28053508 DOI: 10.2147/DDDT.S84667] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
16 Bassetti M, Russo A, Carnelutti A, Wilcox M. Emerging drugs for treating methicillin-resistant Staphylococcus aureus. Expert Opin Emerg Drugs 2019;24:191-204. [PMID: 31590576 DOI: 10.1080/14728214.2019.1677607] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
17 Pulia MS, Calderone MR, Meister JR, Santistevan J, May L. Update on management of skin and soft tissue infections in the emergency department. Curr Infect Dis Rep 2014;16:418. [PMID: 24992977 DOI: 10.1007/s11908-014-0418-9] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
18 Navarro-San Francisco C, Ruiz-Garbajosa P, Cantón R. The what, when and how in performing and interpreting microbiological diagnostic tests in skin and soft tissue infections. Curr Opin Infect Dis 2018;31:104-12. [PMID: 29337704 DOI: 10.1097/QCO.0000000000000433] [Cited by in Crossref: 8] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
19 Peng H, Liu D, Ma Y, Gao W. Comparison of community- and healthcare-associated methicillin-resistant Staphylococcus aureus isolates at a Chinese tertiary hospital, 2012-2017. Sci Rep 2018;8:17916. [PMID: 30559468 DOI: 10.1038/s41598-018-36206-5] [Cited by in Crossref: 19] [Cited by in F6Publishing: 19] [Article Influence: 6.3] [Reference Citation Analysis]
20 Kim T, Park SY, Kwak YG, Jung J, Kim MC, Choi SH, Yu SN, Hong HL, Kim YK, Park SY, Song EH, Park KH, Cho OH, Choi SH; Korean SSTI Study Group. Etiology, characteristics, and outcomes of community-onset necrotizing fasciitis in Korea: A multicenter study. PLoS One 2019;14:e0218668. [PMID: 31220158 DOI: 10.1371/journal.pone.0218668] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
21 Haddad Kashani H, Fahimi H, Dasteh Goli Y, Moniri R. A Novel Chimeric Endolysin with Antibacterial Activity against Methicillin-Resistant Staphylococcus aureus. Front Cell Infect Microbiol 2017;7:290. [PMID: 28713777 DOI: 10.3389/fcimb.2017.00290] [Cited by in Crossref: 33] [Cited by in F6Publishing: 25] [Article Influence: 8.3] [Reference Citation Analysis]
22 Sazdanovic P, Jankovic SM, Kostic M, Dimitrijevic A, Stefanovic S. Pharmacokinetics of linezolid in critically ill patients. Expert Opin Drug Metab Toxicol 2016;12:595-600. [PMID: 27020789 DOI: 10.1517/17425255.2016.1170807] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 3.0] [Reference Citation Analysis]
23 Li X, Chen Y, Gao W, Ouyang W, Wei J, Wen Z. Epidemiology and Outcomes of Complicated Skin and Soft Tissue Infections among Inpatients in Southern China from 2008 to 2013. PLoS One 2016;11:e0149960. [PMID: 26918456 DOI: 10.1371/journal.pone.0149960] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 2.6] [Reference Citation Analysis]
24 Dinarvand M, Spain M. Identification of Bioactive Compounds from Marine Natural Products and Exploration of Structure-Activity Relationships (SAR). Antibiotics (Basel) 2021;10:337. [PMID: 33810102 DOI: 10.3390/antibiotics10030337] [Reference Citation Analysis]
25 Zhao JC, Zhang XH, Zhang N, Wu ZD, Wang J, Yu QH, Hong L, Shi K, Yu JA. Complicated Posterior Cervical Skin and Soft Tissue Infections at a Single Referral Center. Biomed Res Int 2020;2020:5230763. [PMID: 32802854 DOI: 10.1155/2020/5230763] [Reference Citation Analysis]
26 Esposito S, Ascione T, Pagliano P. Management of bacterial skin and skin structure infections with polymicrobial etiology. Expert Rev Anti Infect Ther 2019;17:17-25. [PMID: 30518267 DOI: 10.1080/14787210.2019.1552518] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 2.3] [Reference Citation Analysis]
27 Glibbery N, Gouliouris T, Bewick J. Methicillin-resistant Staphylococcus aureus (MRSA) submandibular abscess in a neonate. BMJ Case Rep 2021;14:e242258. [PMID: 34059545 DOI: 10.1136/bcr-2021-242258] [Reference Citation Analysis]
28 Zhou L, Gao Y, Cao W, Liu J, Guan H, Zhang H, Shi Y, Lv W, Cheng L. Retrospective analysis of relationships among the dose regimen, trough concentration, efficacy, and safety of teicoplanin in Chinese patients with moderate-severe Gram-positive infections. Infect Drug Resist 2018;11:29-36. [PMID: 29379306 DOI: 10.2147/IDR.S146961] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 4.3] [Reference Citation Analysis]
29 Zhou C, Bhinderwala F, Lehman MK, Thomas VC, Chaudhari SS, Yamada KJ, Foster KW, Powers R, Kielian T, Fey PD. Urease is an essential component of the acid response network of Staphylococcus aureus and is required for a persistent murine kidney infection. PLoS Pathog 2019;15:e1007538. [PMID: 30608981 DOI: 10.1371/journal.ppat.1007538] [Cited by in Crossref: 28] [Cited by in F6Publishing: 21] [Article Influence: 14.0] [Reference Citation Analysis]
30 Bassetti M, Del Puente F, Magnasco L, Giacobbe DR. Innovative therapies for acute bacterial skin and skin-structure infections (ABSSSI) caused by methicillin-resistant Staphylococcus aureus: advances in phase I and II trials. Expert Opin Investig Drugs 2020;29:495-506. [PMID: 32242469 DOI: 10.1080/13543784.2020.1750595] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
31 Nathwani D, Dryden M, Garau J. Early clinical assessment of response to treatment of skin and soft-tissue infections: how can it help clinicians? Perspectives from Europe. International Journal of Antimicrobial Agents 2016;48:127-36. [DOI: 10.1016/j.ijantimicag.2016.04.023] [Cited by in Crossref: 18] [Cited by in F6Publishing: 19] [Article Influence: 3.6] [Reference Citation Analysis]
32 Ovchinnikov KV, Kranjec C, Telke A, Kjos M, Thorstensen T, Scherer S, Carlsen H, Diep DB. A Strong Synergy Between the Thiopeptide Bacteriocin Micrococcin P1 and Rifampicin Against MRSA in a Murine Skin Infection Model. Front Immunol 2021;12:676534. [PMID: 34276663 DOI: 10.3389/fimmu.2021.676534] [Reference Citation Analysis]
33 Bassetti M, Castaldo N, Carnelutti A, Peghin M, Giacobbe DR. Tedizolid phosphate for the treatment of acute bacterial skin and skin-structure infections: an evidence-based review of its place in therapy. Core Evid 2019;14:31-40. [PMID: 31308835 DOI: 10.2147/CE.S187499] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
34 Cates JE, Mitrani-Gold FS, Li G, Mundy LM. Systematic Review and Meta-Analysis To Estimate Antibacterial Treatment Effect in Acute Bacterial Skin and Skin Structure Infection. Antimicrob Agents Chemother 2015;59:4510-20. [PMID: 25987628 DOI: 10.1128/AAC.00679-15] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
35 Campanini-Salinas J, Andrades-Lagos J, Gonzalez Rocha G, Choquesillo-Lazarte D, Bollo Dragnic S, Faúndez M, Alarcón P, Silva F, Vidal R, Salas-Huenuleo E, Kogan M, Mella J, Recabarren Gajardo G, Vásquez-Velásquez D. A New Kind of Quinonic-Antibiotic Useful Against Multidrug-Resistant S. aureus and E. faecium Infections. Molecules 2018;23:E1776. [PMID: 30029513 DOI: 10.3390/molecules23071776] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
36 Bassetti M, Righi E, Russo A, Carnelutti A. New Antibiotics for Pneumonia. Clin Chest Med 2018;39:853-69. [PMID: 30390754 DOI: 10.1016/j.ccm.2018.08.007] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 6.0] [Reference Citation Analysis]
37 Bassetti M, Eckmann C, Peghin M, Carnelutti A, Righi E. When to switch to an oral treatment and/or to discharge a patient with skin and soft tissue infections. Curr Opin Infect Dis 2018;31:163-9. [PMID: 29324505 DOI: 10.1097/QCO.0000000000000434] [Cited by in Crossref: 11] [Cited by in F6Publishing: 4] [Article Influence: 5.5] [Reference Citation Analysis]
38 Paulen A, Gasser V, Hoegy F, Perraud Q, Pesset B, Schalk IJ, Mislin GL. Synthesis and antibiotic activity of oxazolidinone-catechol conjugates against Pseudomonas aeruginosa. Org Biomol Chem 2015;13:11567-79. [PMID: 26509593 DOI: 10.1039/c5ob01859e] [Cited by in Crossref: 14] [Cited by in F6Publishing: 6] [Article Influence: 2.8] [Reference Citation Analysis]
39 Lv X, Alder J, Li L, O'Riordan W, Rybak MJ, Ye H, Zhang R, Zhang Z, Zhu X, Wilcox MH. Efficacy and Safety of Tedizolid Phosphate versus Linezolid in a Randomized Phase 3 Trial in Patients with Acute Bacterial Skin and Skin Structure Infection. Antimicrob Agents Chemother 2019;63:e02252-18. [PMID: 30988146 DOI: 10.1128/AAC.02252-18] [Cited by in Crossref: 7] [Cited by in F6Publishing: 3] [Article Influence: 3.5] [Reference Citation Analysis]
40 Bassetti M, Carnelutti A, Righi E. The role of methicillin-resistant Staphylococcus aureus in skin and soft tissue infections. Curr Opin Infect Dis 2017;30:150-7. [PMID: 28079631 DOI: 10.1097/QCO.0000000000000353] [Cited by in Crossref: 20] [Cited by in F6Publishing: 11] [Article Influence: 6.7] [Reference Citation Analysis]
41 Kramer TS, Schwab F, Behnke M, Hansen S, Gastmeier P, Aghdassi SJS. Linezolid use in German acute care hospitals: results from two consecutive national point prevalence surveys. Antimicrob Resist Infect Control 2019;8:159. [PMID: 31649816 DOI: 10.1186/s13756-019-0617-0] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
42 Scott LJ. Ceftaroline Fosamil: A Review in Complicated Skin and Soft Tissue Infections and Community-Acquired Pneumonia. Drugs 2016;76:1659-74. [DOI: 10.1007/s40265-016-0654-4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.8] [Reference Citation Analysis]
43 Jorgensen SCJ, Murray KP, Lagnf AM, Melvin S, Bhatia S, Shamim MD, Smith JR, Brade KD, Simon SP, Nagel J, Williams KS, Ortwine JK, Veve MP, Truong J, Huang DB, Davis SL, Rybak MJ. A Multicenter Evaluation of Vancomycin-Associated Acute Kidney Injury in Hospitalized Patients with Acute Bacterial Skin and Skin Structure Infections. Infect Dis Ther 2020;9:89-106. [PMID: 31983021 DOI: 10.1007/s40121-019-00278-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
44 Milosevic TV, Payen VL, Sonveaux P, Muccioli GG, Tulkens PM, Van Bambeke F. Mitochondrial Alterations (Inhibition of Mitochondrial Protein Expression, Oxidative Metabolism, and Ultrastructure) Induced by Linezolid and Tedizolid at Clinically Relevant Concentrations in Cultured Human HL-60 Promyelocytes and THP-1 Monocytes. Antimicrob Agents Chemother 2018;62:e01599-17. [PMID: 29263063 DOI: 10.1128/AAC.01599-17] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 2.7] [Reference Citation Analysis]
45 Olaniyi R, Pozzi C, Grimaldi L, Bagnoli F. Staphylococcus aureus-Associated Skin and Soft Tissue Infections: Anatomical Localization, Epidemiology, Therapy and Potential Prophylaxis. Curr Top Microbiol Immunol 2017;409:199-227. [PMID: 27744506 DOI: 10.1007/82_2016_32] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 7.5] [Reference Citation Analysis]
46 Houfi AE, Thaqafi AA, Alenazi TH, Farahat F, Solem CT, Stephens JM, Johnson C, Macahilig C, Tang WY, Haider S. Early switch/early discharge opportunities for hospitalized patients with methicillin resistant Staphylococcus aureus complicated skin and soft tissue infections: Saudi Arabia and United Arab Emirates. J Infect Public Health 2020;13:1126-33. [PMID: 32482613 DOI: 10.1016/j.jiph.2020.03.018] [Reference Citation Analysis]
47 Purrello SM, Garau J, Giamarellos E, Mazzei T, Pea F, Soriano A, Stefani S. Methicillin-resistant Staphylococcus aureus infections: A review of the currently available treatment options. J Glob Antimicrob Resist 2016;7:178-86. [PMID: 27889013 DOI: 10.1016/j.jgar.2016.07.010] [Cited by in Crossref: 61] [Cited by in F6Publishing: 50] [Article Influence: 12.2] [Reference Citation Analysis]
48 Das S, Li J, Iaconis J, Zhou D, Stone GG, Yan JL, Melnick D. Ceftaroline fosamil doses and breakpoints for Staphylococcus aureus in complicated skin and soft tissue infections. J Antimicrob Chemother 2019;74:425-31. [PMID: 30380060 DOI: 10.1093/jac/dky439] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 16.0] [Reference Citation Analysis]
49 Dumitrescu O, Lina G. What is the place of linezolid in the treatment of methicillin-resistant Staphylococcus aureus nosocomial pneumonia and complicated skin and soft tissue infections in Europe? Clin Microbiol Infect 2014;20 Suppl 4:1-2. [PMID: 24580737 DOI: 10.1111/1469-0691.12496] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
50 Zhou YF, Li L, Tao MT, Sun J, Liao XP, Liu YH, Xiong YQ. Linezolid and Rifampicin Combination to Combat cfr-Positive Multidrug-Resistant MRSA in Murine Models of Bacteremia and Skin and Skin Structure Infection. Front Microbiol 2019;10:3080. [PMID: 31993042 DOI: 10.3389/fmicb.2019.03080] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
51 Esposito S, Bassetti M, Bonnet E, Bouza E, Chan M, De Simone G, Dryden M, Gould I, Lye DC, Saeed K, Segreti J, Unal S, Yalcin AN; International Society of Chemotherapy (ISC). Hot topics in the diagnosis and management of skin and soft-tissue infections. Int J Antimicrob Agents 2016;48:19-26. [PMID: 27216380 DOI: 10.1016/j.ijantimicag.2016.04.011] [Cited by in Crossref: 30] [Cited by in F6Publishing: 25] [Article Influence: 6.0] [Reference Citation Analysis]
52 Simon P, Busse D, Petroff D, Dorn C, Ehmann L, Hochstädt S, Girrbach F, Dietrich A, Zeitlinger M, Kees F, Kloft C, Wrigge H. Linezolid Concentrations in Plasma and Subcutaneous Tissue are Reduced in Obese Patients, Resulting in a Higher Risk of Underdosing in Critically Ill Patients: A Controlled Clinical Pharmacokinetic Study. J Clin Med 2020;9:E1067. [PMID: 32283731 DOI: 10.3390/jcm9041067] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
53 Leong HN, Kurup A, Tan MY, Kwa ALH, Liau KH, Wilcox MH. Management of complicated skin and soft tissue infections with a special focus on the role of newer antibiotics. Infect Drug Resist 2018;11:1959-74. [PMID: 30464538 DOI: 10.2147/IDR.S172366] [Cited by in Crossref: 26] [Cited by in F6Publishing: 10] [Article Influence: 8.7] [Reference Citation Analysis]
54 Esposito S, Bassetti M, Concia E, De Simone G, De Rosa FG, Grossi P, Novelli A, Menichetti F, Petrosillo N, Tinelli M, Tumbarello M, Sanguinetti M, Viale P, Venditti M, Viscoli C; Italian Society of Infectious and Tropical Diseases. Diagnosis and management of skin and soft-tissue infections (SSTI). A literature review and consensus statement: an update. J Chemother 2017;29:197-214. [PMID: 28378613 DOI: 10.1080/1120009X.2017.1311398] [Cited by in Crossref: 34] [Cited by in F6Publishing: 10] [Article Influence: 8.5] [Reference Citation Analysis]
55 Bassetti M, Peghin M, Castaldo N, Giacobbe DR. The safety of treatment options for acute bacterial skin and skin structure infections. Expert Opin Drug Saf 2019;18:635-50. [PMID: 31106600 DOI: 10.1080/14740338.2019.1621288] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 6.0] [Reference Citation Analysis]
56 Grewal M, Gupta S, Muranjan M, Karande S. Managing pulmonary embolism secondary to suppurative deep vein thrombophlebitis due to community-acquired Staphylococcus aureus in a resource-poor setting. J Postgrad Med 2018;64:164-9. [PMID: 29943741 DOI: 10.4103/jpgm.JPGM_548_17] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
57 Kollipara R, Downing C, Lee M, Guidry J, Curtis S, Tyring S. Current and emerging drugs for acute bacterial skin and skin structure infections: an update. Expert Opinion on Emerging Drugs 2014;19:431-40. [DOI: 10.1517/14728214.2014.955015] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.1] [Reference Citation Analysis]